BioCryst Pharmaceuticals Inc (BCRX) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $7.90
• Market Cap: $1.89B
• EPS: $-0.05
• 52-Week High: $11.31
• 52-Week Low: $6.00

Market Sentiment

BioCryst Pharmaceuticals Inc currently has a Bullish sentiment score of 0.40.

About BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc. is a cutting-edge biotechnology company headquartered in Durham, North Carolina, dedicated to pioneering oral and small molecule therapeutics for rare diseases. The company’s robust pipeline features innovative treatments aimed at addressing significant unmet medical needs, with a particular emphasis on hereditary angioedema and viral infections. BioCryst is recognized for its scientific rigor and nimble approach to drug development, making it an appealing inves...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for BioCryst Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BCRX pay dividends?

BioCryst Pharmaceuticals Inc (BCRX) does not currently pay a regular dividend.

What is BCRX's market cap?

BioCryst Pharmaceuticals Inc (BCRX) has a market capitalization of $1.89B with a current stock price of $7.90.